These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11585632)

  • 1. Antibody pattern analysis in the Guillain-Barré syndrome and pathologic controls.
    Dziewas R; Kis B; Grus FH; Zimmermann CW
    J Neuroimmunol; 2001 Oct; 119(2):287-96. PubMed ID: 11585632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilus influenzae infection and Guillain-Barré syndrome.
    Mori M; Kuwabara S; Miyake M; Noda M; Kuroki H; Kanno H; Ogawara K; Hattori T
    Brain; 2000 Oct; 123 ( Pt 10)():2171-8. PubMed ID: 11004133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibodies targeting neurons of the monoaminergic systems in Guillain-Barré syndrome.
    Rink C; Görtzen A; Veh RW; Prüss H
    J Neurol Sci; 2017 Jan; 372():318-323. PubMed ID: 28017237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannose-binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders.
    Farrokhi M; Dabirzadeh M; Dastravan N; Etemadifar M; Ghadimi K; Saadatpour Z; Rezaei A
    Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):251-6. PubMed ID: 27424141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis.
    Orlikowski D; Chazaud B; Plonquet A; Poron F; Sharshar T; Maison P; Raphaël JC; Gherardi RK; Créange A
    J Neuroimmunol; 2003 Jan; 134(1-2):118-27. PubMed ID: 12507779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory B cells in Guillain-Barré syndrome.
    Wang Q; Xing C; Hao Y; Shi Q; Qi Z; Lv Z; Song Y; Xu P; Feng X; Zhang L; Zhang Y; Wang Y; Yuki N
    J Neuroimmunol; 2017 Apr; 305():1-4. PubMed ID: 28284328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal proteins are target antigens in Guillain-Barré syndrome.
    Devaux JJ; Odaka M; Yuki N
    J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome associated with CASPR2 antibodies: two paediatric cases.
    Rosch RE; Bamford A; Hacohen Y; Wraige E; Vincent A; Mewasingh L; Lim M
    J Peripher Nerv Syst; 2014 Sep; 19(3):246-9. PubMed ID: 25413786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome.
    Nakane S; Higuchi O; Hamada Y; Maeda Y; Mukaino A; Sakai W; Kusunoki S; Matsuo H
    J Neuroimmunol; 2016 Jun; 295-296():54-9. PubMed ID: 27235349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategies in the Guillain-Barré syndrome.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):159-68. PubMed ID: 12894381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.
    Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; Drenthen J; Unger WWJ; Jacobs E; van Rossum AMC; Jacobs BC
    J Neuroimmunol; 2018 Jan; 314():13-16. PubMed ID: 29301655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.
    Ariga T; Yu RK
    J Neurosci Res; 2005 Apr; 80(1):1-17. PubMed ID: 15668908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome.
    Helgeland G; Petzold A; Hoff JM; Gilhus NE; Plant GT; Romi FR
    J Neuroimmunol; 2010 Aug; 225(1-2):180-3. PubMed ID: 20554026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.